If You Like to Find The Best Penny Stocks to Buy, Screening For Technical Trends Helps Narrow Down The List
Using penny stock screeners may be a good place to start making your list of penny stocks. Unless you’re watching each and every announcement that hits the press wire, you’ll likely be able to catch a technical move sooner than a fundamental one. Though there are some who constantly are on the lookout for actionable penny stock news. In this case, they’re likely glued to their computer screens for hours at a time until they find the best penny stocks with big news.
Needless to say, you’ll likely catch an alert sooner by scanning for things like higher volume or, at least, irregular volume. At this time, you could find out if or why penny stocks are moving and if it’s because of an announcement or something else. Personally, scanning for things like irregular price movement and share trading volume for stocks trading under a certain price point is a good place to begin. If you like higher priced penny stocks, you could set the price limit to $5 or less. If you like cheaper stocks, try setting your price limit at $1 or $2 and below.
Whatever you decide, make sure it fits your strategy. There are countless screening tools out there and we even have some of our own right on PennyStocks.com. If you buy penny stocks on Robinhood, there’s an even easier way to find low priced stocks. Check out our article, “How To Buy Penny Stocks On Robinhood.”
With this in mind, here are 5 penny stocks that can be bought for under $1.50 as of September 3.
Penny Stocks To Buy (Under $1.50) #5: Hudson Technologies Inc. (HDSN)
This has been one of the penny stocks to watch on PennyStocks.com for a few weeks now. Hudson Technologies (HDSN Stock Report) hit 52-week lows on August 23 but has since taken off big. On September 3, the penny stock tagged new 30 day highs of $0.68. This is great as HDSN stock is up since our initial update.
But why have shares moved up like this? Well, for starters, you won’t find any recent news from the penny stock. The last update was about a bad second quarter. As always, however, you need to look “behind” the reports. What I mean is look at things like filings and look for verified articles from reputable sources that may have an inside track on the company’s local operations.
In this case, a flood of FORM 4 filings shows insiders are buying up HDSN stock. In fact, filings submitted on Aug 29 show big volume coming from corporate directors including Vincent Abbatecola, Richard Parrillo, Eric Prouty, and Otto Morch.
Penny Stocks To Buy (Under $1.50) #4: India Globalization Capital (IGC)
As with many sectors that include microcap stocks, pot stocks are beginning to pick up steam this month. India Globalization Capital (IGC Stock Report) has followed suit. The penny stock has been beaten down for quite some time. But on September 3, shares perked up late in the afternoon. IGC stock shot up from roughly $1 a share to highs of $1.17 before closing the day at $1.10.
India Globalization is no stranger to controversy. The series of “ambulance-chasing” press releases from several law offices can show you that. But why did the marijuana stock jump? Though there was no direct news from the company, a number of pot penny stocks ran on Tuesday.
Part of the reason the sector saw attention had to do with continued speculation on Canada’s next move to legalize cannabis derivative like extracts this coming October. In addition, the DEA has also put out some news pointing at progress for cannabis companies.
Penny Stocks To Buy (Under $1.50) #3: Teligent Inc. (TLGT)
Another one of the penny stocks without news, Teligent Inc. (TLGT Stock Report) continued its run from August. Shares of the generic drug company have now moved up from about $0.70 last week to highs of $1.05 to start September. Considerable trading volume has also come into this stock over the last 3 consecutive trading days.
But again, TLGT stock hasn’t reported anything since the beginning of August. So why is this penny stock running so hard? As with other industries, pharmaceuticals tend to react to sector news. Generic drug company Lannett Co recently reported its Q4 results.
[Read More] How To Buy Penny Stocks On Robinhood
Those included bullish fiscal 2020 guidance. Sometimes positive news from a larger company can lift hopes for investors looking at cheaper names. Teligent could have been the beneficiary. But will this remain one of the penny stocks to buy this month?
Penny Stocks To Buy (Under $1.50) #2: Sunesis Pharmaceuticals (SNSS)
Add this penny stock to the list of penny stocks without news. Sunesis Pharmaceuticals (SNSS Stock Report) was up big on September 3. Starting off the new month, SNSS stock jumped from and open of $0.8188 to highs of $0.98. But yet again, there were no material events on the press or disclosure wires.
So what could have helped SNSS stock? Well, a quick look back at the last announcement shows Sunesis will be presenting at the Wells Fargo Healthcare Conference on September 4.
This is one of the larger healthcare conferences in the industry and hosts other names like Teladoc, UnitedHealth Group, and Novartis. Sunesis will join the ranks alongside them and gain exposure to the same investors interested in those companies as well.
Penny Stocks To Buy (Under $1.50) #1: Histogenics Corporation (HSGX)
This has been a penny stock to watch for most of the month of August. What has investors so focused on Histogenics Corporation (HSGX Stock Report) is the pending merger with Ocugen. Under the terms of the deal, Ocugen will be the prevailing company in a stock-for-stock merger.
Management remains favorable about the deal and even Histogenics CEO Adam Gridley sees an opportunity through the deal. “Following a thorough review of strategic alternatives for Histogenics and the NeoCart program, we have determined that a merger with Ocugen will enable Histogenics investors to participate in Ocugen’s broader pipeline of ocular disease and gene therapy opportunities, including several late-stage clinical candidates, and a robust preclinical platform.”
Though the stock is nowhere near it’s price last year, HSGX stock has been on a slow and steady climb for most of the year. Keep in mind that the stock traded at roughly $0.09 at the start of 2019. Needless to say, Histogenics remains of penny stock to watch in September.
One of the reasons has to do with a single sentence from the company’s original merger announcement in April. “The transaction is expected to close in late second quarter or third quarter of 2019, subject to approvals by stockholders of each company and other customary closing conditions.”